Home Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain By - September 27, 2022 28 0 Facebook Twitter Pinterest WhatsApp The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Industry-first quality solution for scaling genAI adoption Pilots - February 23, 2024 0 GE completes healthcare division spinoff Pilots - January 4, 2023 0 Munich-based Wellster raises $60M to launch European femtech platform Pilots - January 24, 2022 0 Provider search firm Kyruus buys patient engagement company Epion Health Pilots - September 15, 2022 0 Roundup: PatientSource solution eliminates manual data gathering at Israeli hospital, Florence raises £28.5M to... Pilots - June 2, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3